Impact of nationwide measles vaccination campaign among children aged 9 months to 14 years, Zimbabwe, 1998-2001

被引:8
作者
Munyoro, MN
Kufa, E
Biellik, R
Pazvakavambwa, IE
Cairns, KL
机构
[1] WHO, Expanded Programm Immunizat, Harare, Zimbabwe
[2] Univ Zimbabwe, Sch Med, Dept Pediat, Harare, Zimbabwe
[3] WHO, So African Reg Off, Harare, Zimbabwe
[4] Ctr Dis Control & Prevent, Global Measles Branch, Global Immunizat Div, Natl Immunizat Program, Atlanta, GA USA
关键词
D O I
10.1086/368116
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Zimbabwe (population 11,365,000) introduced nationwide one-dose measles vaccination in 1981. This strategy reached 70%-80% of infants <1 year of age over the next two decades; in 1998, a nationwide supplemental immunization activity (SIA) targeting all children aged 9 months to 14 years achieved 93% coverage. Surveillance data were examined to determine the impact of these strategies. During 1985-1997, there were 8529-49,812 measles cases annually. After the SIA, laboratory confirmation of the first 5 outbreak cases and all sporadic cases was required. In 1999 and 2000, 1343 (88%) of 1534 suspected cases had adequate specimens submitted and 28 (2%) were measles IgM positive. In 2001, of 529 suspected cases, 513 (97%) had adequate specimens and only 7 (1%) were measles IgM positive. These data suggest that indigenous measles transmission in Zimbabwe has been interrupted and that high prevalence of human immunodeficiency virus seropositivity does not hinder vaccination-induced measles control. High vaccination coverage obtained through the routine health care system supplemented by periodic follow-up SIAs will be required to maintain low transmission levels.
引用
收藏
页码:S91 / S96
页数:6
相关论文
共 17 条
  • [1] PREDICTING THE IMPACT OF MEASLES VACCINATION IN ENGLAND AND WALES - MODEL VALIDATION AND ANALYSIS OF POLICY OPTIONS
    BABAD, HR
    NOKES, DJ
    GAY, NJ
    MILLER, E
    MORGANCAPNER, P
    ANDERSON, RM
    [J]. EPIDEMIOLOGY AND INFECTION, 1995, 114 (02) : 319 - 344
  • [2] Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa
    Benn, CS
    Aaby, PA
    Bale, C
    Olsen, J
    Michaelsen, KF
    George, N
    Whittle, H
    [J]. LANCET, 1997, 350 (9071) : 101 - 105
  • [3] Effect of vitamin A supplementation on measles-specific antibody levels in Guinea-Bissau
    Benn, CS
    Balde, A
    George, E
    Kidd, M
    Whittle, H
    Lisse, IM
    Aaby, P
    [J]. LANCET, 2002, 359 (9314) : 1313 - 1314
  • [4] First 5 years of measles elimination in southern Africa: 1996-2000
    Biellik, R
    Madema, S
    Taole, A
    Kutsulukuta, A
    Allies, E
    Eggers, R
    Ngcobo, N
    Nxumalo, M
    Shearley, A
    Mabuzane, E
    Kufa, E
    Okwo-Bele, JM
    [J]. LANCET, 2002, 359 (9317) : 1564 - 1568
  • [5] *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P57
  • [6] *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P513
  • [7] Measles elimination in the Americas - Evolving strategies
    deQuadros, CA
    Olive, JM
    Hersh, BS
    Strassburg, MA
    Henderson, DA
    BrandlingBennett, D
    Alleyne, GAO
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (03): : 224 - 229
  • [8] *HLTH CAN, 1997, CAN COMMUN DIS RE S4, V23
  • [9] *MIN HLTH CHILD WE, 1998, 1998 MEASL CAMP REP
  • [10] Implications of the human immunodeficiency virus epidemic for control and eradication of measles
    Moss, WJ
    Cutts, F
    Griffin, DE
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 29 (01) : 106 - 112